Abstract A laboratory notebook contains a wealth of knowledge that can be critical for establishing evidence in support of intellectual property rights and for refuting claims of research misconduct. The proper type, organization, use, maintenance, and storage of laboratory notebooks should be a priority for everyone at research institutions. Failure to properly document research activities can lead to serious problems, including the loss of valuable patent rights. Consequences of improper laboratory notebook practices can be harsh; numerous examples are described in court cases and journal articles, indicating a need for research institutions to develop strict policies on the proper use and storage of research documentation.
Introduction
The laboratory notebook is an essential tool for researchers in both university and industry settings. Most researchers view laboratory notebooks as important organizational tools that allow them to document their work, thereby creating a record that can be used to support future projects. However, laboratory notebooks have additional important functions often overlooked; such as to (1) support intellectual property rights and (2) protect the researcher from accusations of research misconduct. In this article, we will focus mainly on the laboratory notebook's role for supporting intellectual property rights.
What happens if an institution's patent is challenged or a researcher is accused of scientific misconduct? Typically, the first step includes looking into the laboratory notebooks for support or rebuttal. If no laboratory notebooks can be found or the entries of the notebooks are not credible, the problems can become much more difficult to overcome. Many universities and companies have had to face these situations, which can result in negative publicity for both the researchers involved and their institutions. Furthermore, patent rights may be lost or the researcher may be found guilty of misconduct or fraud. In industry, most pharmaceutical companies have strict policies in place for managing laboratory notebooks and other research documentation. However, many universities do not have such strict policies despite their demonstrable importance.
Purpose of lab notebooks as support for intellectual property rights
Laboratory notebooks can be critical pieces of evidence for intellectual property. The USA has a "first-to-invent" system of patent law where the inventor with the earliest date of invention is entitled to the patent, whereas the rest of the world operates under "first-to-file" systems where the first person or entity to file the patent application has claim to the invention. In the USA, therefore, being able to show evidence of the date of invention is the most important factor for obtaining rights to an invention in a competitive area of research.
The act of inventing is comprised of two steps: (1) conception of the invention and (2) actual or constructive reduction of the invention to practice. Conception is the formation of the invention in the mind of the inventor as a definite composition of the invention. Reduction to practice is actually building and performing the invention or constructively describing it in great enough detail in a patent application. Further, diligence of working on the invention during the time from conception to the reduction of practice is also required.
Demonstration of being the first to invent can be necessary at various stages of the patent's life. During patent prosecution before the US Patent and Trademark Office (USPTO), it may be necessary to "swear behind" a prior art reference by declaring that the inventor performed the acts of invention prior to the reference being relied upon by a USPTO examiner for their rejection of a patent application claim. Also, during patent prosecution, an interference action may occur if another patent applicant has claims to the same invention. If such a circumstance occurs, it is the USPTO Board of Patent Appeals and Interferences that determines who was the first to invent. Additionally, after a patent issues, litigation in court may require establishing an inventor as the first to invent to uphold the patent's validity or to undermine an oppositions patent. As one can imagine, a laboratory notebook can be essential evidence in all of these scenarios regarding patent rights.
Another important aspect of intellectual property rights is properly determining inventorship. Incorrect inventorship can seriously complicate any licensing arrangement or even invalidate a patent. Properly maintained laboratory notebooks can provide a reliable means of determining inventorship. Thus, inventorship is a critical question that needs to be determined before a patent is filed and then revisited again once claims in the patent application are allowed as a coinventor's contribution may have been removed in an amendment of the claim set.
Many times, investigators feel that anyone who provided experimental work should be considered an inventor. However, unlike journal articles where a variety of contributors are often listed as authors, to be an inventor on a patent one has to contribute to the conception of the invention. Identifying inventors can often be a difficult task, but if laboratory notebooks are properly maintained it can provide a clear record of who conceived the idea for the invention, which will allow you to avoid potential conflicts down the road. For example, in Stern v. Trs. Of Columbia Univ. (434 F.3d 1375 , Fed. Cir. 2006 , Stern was a medical student at Columbia University conducting research under Lazlo Bito on prostaglandins and intraocular pressure. After Stern departed Columbia, Bito applied for and was awarded a patent on a method of treating glaucoma. Upon learning of the patent, Stern brought suit seeking to be added to the patent as coinventor. According to the court, a coinventor must contribute to the conception of the invention and the contribution must be to at least one claim in the patent. Stern was not a coinventor as he did not have an understanding of the claimed invention, did not discover that prostaglandins had an effect on intraocular pressure, did not conceive of the idea to use prostaglandins for the treatment of glaucoma, and did not collaborate with Bito on the glaucoma treatment. Stern simply carried out an experiment already done by Bito but on a different animal model, which Bito had demonstrated would be good for prostaglandin research.
Proper laboratory notebook practices
In order for a laboratory notebook to be used as evidence in the support of intellectual property rights, it must meet specific criteria. Proper laboratory notebooks must be of a type of book that is bound at the binding to prevent the possibility of easily inserting or removing pages, thereby increasing confidence that there has been no tampering with the notebook. Lab notebooks should never consist of looseleaf paper or have a spiral binding. In addition, laboratory notebooks should contain a table of contents and have consecutively numbered pages.
To further ensure the authenticity and credibility of the laboratory notebook, it is important that entries adhere to some specific guidelines. All entries should be dated. This will provide evidence of when an invention is conceived and when it is reduced to practice. All entries should be made in permanent ink to prevent smearing or erasing. It is also important to not leave blank spaces on any of the pages in the laboratory notebook which could allow someone to come back at a later time and make an entry on the earlier dated page. If a blank space is unavoidable, it should have a line drawn through that section of the page. An error, such as a miscalculation, in the laboratory notebook should have a single line drawn through it and be initialed by the researcher. White-out or scribbling over an entry should be avoided.
Attachment of data is also a critical aspect of properly maintaining a laboratory notebook. Any data inserts must be taped, or preferably glued, into the laboratory notebook, ensuring that adhesive is placed along all four sides. Once in place, the researcher should sign and date the insert so that the signature and date start on the data insert, cross the site of attachment, and end on the underlying sheet. This ensures that there will be evidence of the removal or loss of any data insert from the laboratory notebook.
Two of the most important aspects of a laboratory notebook are the signature and witness lines. Laboratory notebooks should have spaces for both the researcher's signature and a witness' signature. Every page should be signed by the researcher and witnessed. To be used as evidence, the laboratory notebook must have the quality and reliability of evidence as being relevant, authentic, and not hearsay. Furthermore, the laboratory notebook must have credibility as a trustworthy source to carry any weight for convincing the court. In order for the laboratory notebook to have any significance as evidence in court, there must be corroboration of the work conducted. Rule 902 of the Federal Rules of Evidence provides the types of documents that do not require additional corroboration of authenticity and as such can be submitted as evidence. These types of documents are referred to as selfauthenticating. However, laboratory notebooks are considered non-self-authenticating documents and therefore must have corroboration, "Any printed publication or other document which is not self-authenticating shall be authenticated and discussed with particularity in an affidavit" (37 CFR 1.608(b)). The witness' signature for the laboratory notebook entry provides a means of corroborating the authenticity of the work. Without a witness, a laboratory notebook carries little weight as evidence due to a lack of corroboration. For example, in Chen v. Bouchard (347 F.3d 1299, Fed. Cir. 2003), Chen's uncorroborated lab notebooks were excluded as hearsay and unauthenticated evidence, undermining his assertion of being the first to invent a certain derivative of Taxol®.
This leads to the questions of who should be the witness and what does the witness actually do? Choosing the wrong person to act as a witness may be equivalent to not having one at all. The witness needs to be a person who is knowledgeable in the subject area of the entry and who can understand the importance of the work being documented. However, the witness should not be anyone who is directly associated with the project and who would have ownership in the associated work. The witness should review the research and understand its significance before signing. Ideally, laboratory notebooks should be witnessed daily; however, this is not always practical. Instead, it is good to have time set aside every week or at least every other week to have laboratory notebooks reviewed and witnessed.
Finally, it is important to have the entries in the laboratory notebook organized. Each experiment should be given a title and identification number that are also listed in the table of contents. A rationale should be included explaining why the experiments are being conducted. Experiments should be ordered chronologically. All essential elements used in the experiment should be listed, such as protocol, reagents, and calculations just to name a few. Use complete descriptions and accurately describe the methods used to carry out the experiments. Any abbreviations used that are not common knowledge need to be defined. For example, in Hybritech, Inc., v. Monoclonal Antibodies, Inc. (802 F.2d 1367 , Fed. Cir. 1986 ), Monoclonal was unable to establish actual reduction to practice of the invention at an earlier date because the laboratory notebooks did not identify the chemical reagents or protocols used. An evaluation and conclusion for each experiment should be recorded. However, care should be taken when explaining results. It is important to not overspeculate or disparage any results, as this type of entry can weaken the validity of the research. These suggestions provided here can help to create a strong and welldocumented laboratory notebook (Fig. 1) .
Storage of laboratory notebooks
An often overlooked aspect of the laboratory notebook in the university setting is proper storage of the active as well as the completed notebooks. This has major implications for both intellectual property rights and defense against research misconduct allegations. Typically, in the pharmaceutical industry, lab notebooks are individually numbered and checked out to scientists. Upon completion of the notebook, they are archived and many companies also create microfilm copies (Du and Kofman 2007 Fig. 1 A checklist of common rules to follow and bad practices to avoid left up to a principal investigator who too often undervalues the long-term importance of the laboratory notebooks. There are numerous examples of poor storage and maintenance of university-based research records. A recent survey reported that over 50% of university officials involved in the investigation of research misconduct had their investigations hampered by inadequate research records (Schreier et al. 2006) . A survey of NIH-funded researchers revealed that around 27% of the researchers admitted to maintaining inadequate record keeping for research projects (Martinson et al. 2005) . Also, a well-publicized case involving the retraction of two research articles listed the loss of laboratory notebooks as a major contributing factor to the author's inability to reproduce results (Service 2009 ). These findings are quite shocking and demonstrate a serious need for the adoption of stringent documentation policies by universities.
It is surprising that many institutions do not take proper precautions to ensure the safety of these documents since the data contained in the laboratory notebook are usually considered as intellectual property owned by the university. Therefore, in the interest of protecting future intellectual property and providing quick resolutions to accusations of research misconduct, it would be in a university's best interest to adopt policies similar to the pharmaceutical industry for the maintenance of research-related records.
New technology: electronic laboratory notebooks
Research laboratories are reliant on computers now more than ever. Laboratories commonly use computers to collect, analyze, format, and store data. With this increasing reliance on computers in research, there are concerns that the standard paper laboratory notebook is becoming obsolete. In the pharmaceutical industry, there has been a strong push toward the transition from paper to electronic laboratory notebooks (ELNs) (Du and Kofman 2007 ). An ELN is a software program that has been created to specifically replace the use of paper-based laboratory notebooks. These programs allow the user to record experiments, collect and enter data, sign and date entries, and obtain a signature from a witness. ELNs provide easy access for the user to search records, decreasing the time needed to find and compile data. They also allow principal investigators to review and authorize work done by laboratory members and provide support for collaboration among many users (Goddard et al. 2009 ).
To date, numerous pharmaceutical companies have implemented ELNs to varying extent, including Merck, GlaxoSmithKline, AstraZeneca, and Eli Lilly (Du and Kofman 2007) . However, academic laboratories have been slow to move in this direction. In fact, a recent survey has shown that only around 4% of researchers in nonprofit institutions have adopted some form of an ELN (Elliot 2008 ). Two of the major drawbacks have been cost and inflexibility of these programs (Goddard et al. 2009 ). ELNs were originally designed for specialized use in the pharmaceutical industry, being tailored for specific research purposes (Goddard et al. 2009; Du and Kofman 2007) . However, this is not useful for the academic research community where day-to-day activities can vary greatly. Therefore, it is necessary for the creation of a flexible ELN system that can accommodate a wide variety of research methods. Recent advances in ELNs, such as the creation of web-based solutions, could help decrease cost and increase the flexibility and utility of these systems for use in academic institutions (Goddard et al. 2009 ). As ELNs adapt to fit the needs of academic research laboratories, there undoubtedly will be a surge of interest in this technology, as it will help streamline research documentation and help increase overall productivity.
Despite the use of ELNs within the pharmaceutical industry, there are still major concerns about the validity of ELN records, especially in their use to support government submissions and intellectual property claims. The FDA does accept the use of electronic signatures and electronic records, assuming the systems comply with 21 CFR Part 11. However, at this time, the USPTO does not have an official stance regarding the specific use of ELNs for evidence of invention in patent cases. Until courts have addressed the issue and stated the acceptance of ELNs in the support of patent claims, there should be hesitation among institutions to transition completely away from paper laboratory notebooks. As ELNs are still maturing, only cautious reliance on them can be given and any ELN being considered should be scrutinized for compliance to relevant regulations, general security, and overall reliability. In another case, Medichem, S.A. v. Rolabo, S.L. (437 F.3d 1157 , Fed. Cir. 2006 , which concerned patent rights to a process for making loratadine (the active ingredient in Claritin®), laboratory notebook practices were apparently quite poor as neither party could assert a conception date in court. Therefore, in this instance, the court considered the first inventor as the one to first reduce the invention to practice. Medichem purported to have actual reduction to practice first. Evidence of reduction to practice requires an actual embodiment produced meeting all the claimed limitations, a showing that the invention would work, and corroboration evidence of each. The purpose of corroboration is to provide independent confirmation of the inventor's testimony and give credibility to the evidence. Medichem's laboratory notebooks were not witnessed and therefore were not corroborated. A noninventor researcher from Medichem also had a laboratory notebook concerning the experiments; however, her notebook was not signed or witnessed and she did not testify for Medichem. Therefore, Medichem did not have enough corroboration of its asserted priority of actual reduction to practice and the patent rights were awarded to Rolabo.
Laboratory notebooks played an important role in the interference case of Brown v. Barbacid (436 F.3d 1376 , Fed. Cir. 2006 , where both claimed to have invented a method for inhibiting cell growth control factors involving farnesyl transferase. Brown conceived of the invention first, but Barbacid reduced the invention to practice before Brown. The first party to conceive an invention, even if not the first to reduce it to practice, is entitled to the patent rights as long as the first party exercised diligence in working on the invention from the date of conception. Furthermore, the inventor's diligence must be corroborated. Brown provided supported evidence from laboratory notebooks to show sufficient activity toward reducing the invention to practice and overcame the challenge to the patent rights.
Many almost unbelievable examples of "don'ts" for laboratory notebook practices are described in Aptix Corp. v. Quickturn Design Systems (269 F.3d 1369 , Fed. Cir. 2001 , where the court refused to enforce the Aptix patent because it submitted falsified laboratory notebooks to the court. The inventor for Aptix submitted falsified laboratory notebook pages dated 1988 in an attempt to proffer an earlier conception date for the field programmable circuit board invention in order to predate potentially invalidating prior art. Discrepancies between his deposition and court testimony eventually elicited a concession from the inventor that he added entries to the laboratory notebook after they had been signed.
Initially, the Aptix inventor only submitted copies of the laboratory notebooks to the court, insisting on personally keeping the original notebooks in a locked safe at his house. However, upon Quickturn's move to compel production of the original notebooks for forensic testing, the inventor stated he had recently taken them to work and left them in his car for the entire day, where sometime during the day his car window was broken and the notebooks stolen. The court even stated that the circumstances of this theft appeared staged by the inventor.
Additional evidence from the inventor's 1988 Daytimer, which referred to the stolen notebooks, was submitted to the court to establish the conception date in place of the 1988 notebook. However, forensic evidence showed that these entries were written with an ink that was not manufactured until 1994. Then, shortly before an evidentiary hearing at which Aptix would have to show that the original notebooks were not destroyed in bad faith, the inventor purportedly received the notebooks back from an anonymous person who sent them by mail to the inventor stating they found his address in a notebook document even though the document states the wrong zip code for his address but the package had the correct zip code. Additionally, the witnessing of the laboratory notebook appeared to have five instances of overwriting the date from 1998, the year it was submitted as evidence, to 1988. The witness was actually the inventor's brother and many of the pages that were signed as "read and understood" were blank pages of the notebook. Further, all witnessing was done with the same ink despite some entries being dated 22 days apart.
The court concluded that the 1988 notebook was a complete fraud and thereby Aptix lost the case. Furthermore, Aptix was ordered to pay attorney fees and costs of $4.2 million to Quickturn.
Conclusions
Laboratory notebooks are critical tools for researchers; they provide a way for researchers to document their work while also creating corroborated evidence of the conception and reduction to practice of their research. A properly maintained laboratory notebook is critical for supporting patent rights and refuting accusations of potential misconduct or fraud. As one can see from the various case studies presented in this paper, laboratory notebooks have proven to be key pieces of evidence in cases concerning intellectual property and often decided the fate of patent rights to multimillion dollar technologies. Therefore, it is suggested that universities and other research institutions place increased importance on the proper maintenance and storage of laboratory notebooks. Creation of stringent policies covering the use of laboratory notebooks could save universities and other institutions from the humiliation of fraud convictions or from the loss of valuable intellectual property rights.
